Директор по маркетингу (фарма) / marketing director (pharma)

Описание

RESUME
Dr. Valery I. Buvaltsev, MD, MBA

Citizenship: Russia
Address: Moscow.
Tel. +7(915) 468-333-7 (mobile),
e-mail: vbuvaltsev@yandex.ru.

Job opportunities interest in: Medical Director in international pharmaceutical company.

Executive summary:
* Certified Professor of Medicine, PhD and Dr. Med Sci degrees in general medicine and cardiology
* Unique managerial experience in multinational pharmaceutical companies with Rx and orphan products in medical and business roles
* Strong skills and competencies in:
* Medical strategy
* Clinical and pre-clinical research
* Medical statistics and medical writing
* HTA
* KOL management
* MSL management
* Pharmacovigilance
* Launch and re-launch management
* Market access strategy
* Change management
* Team Management in cross-functional organizations (direct and indirect management of 5 to 150 employees) with full responsibility for P/L, organizational culture, SOPs and compliance
* Business specializations: Medical Affairs, Marketing and Sales,
* Top career positions achieved: Medical Director, Chief strategic development officer, BU Director

EMPLOYMENT HISTORY in Brief

Stentex LLc (JV Medtronic/RENOVA Gr.), 2016Y-current,
Strategic Development Director/ Medical Director
Janssen Cilag (Johnson & Johnson), 2013 - 2016, Medical Manager
Bristol-Myers Squibb, 2011 - 2013, Business Unit Director
BAYER, 2009 - 2011, Business Unit Director
Pliva Hrvatska (TEVA), 2004-2009, Marketing Director
BERLIN-CHEMIE / MENARINI Group, 1998 - 2004, Group Product Manager
BOEHRINGER INGELHEIM Pharma GmbH, 1996 - 1998, Product Manager
Russia State Medical University, 1988-1996, Associate Professor


EMPLOYMENT HISTORY in details

Stentex LLC (Joint venture of Medtronic plc. and Renova Group), Moscow, April, 2016-current. Medical Director; Chief strategic development officer.
Remarks:
* Launched Medical function in the company:
o continuous medical education for internal and external clients,
o patients awareness programs
o clinical, pre-clinical and clinical economic programs
o publications in international journals
o clinical vigilance and quality management,
o KOL management and Advisory Boards,
o Supervision of business ethics and compliance
* Initiated the company medical re-launch
* Update of National Standards of Care in ACS
* Leading role in the company for medical and market development strategy
* Introduced the Company at external meetings including negotiations with regional Ministries of Health, conferences and mass-media
* New businesses searches and negotiations with potential partners

Janssen Cilag (Johnson & Johnson corporation), Moscow, July, 2013 - April, 2016.
Medical Manager.
* Direct manager of the team - 6 medical advisers and 4 MSLs.
* Remarks:
o Led all aspects of Medical affairs, including medical strategy, special projects (as Advisory Boards program, National projects), clinical trials program, pharmacovigilance, education programs
o Managed the company medical teams in Virology (HIV and Hepatitis), Primary Care (Diabetes, Neurology, Psychiatry), Rheumatology/Dermatology (monoclonal antibodies).
o Led market and company preparation, medical and market access launches of the new Multiple sclerosis pipe-line ("Biogen" partnership), new antidiabetic class (Invokana), scientific re-launch of mature product Pariet (gastroenterology)
o Pharmaco-economic studies and modeling in alliance with KOLs and market access department
o Successful preparation of reimbursement dossiers in "7 Nosologies", Standards of care updates and their approval by MoH,
o KOLs management
o New businesses development assessment
o Data generation and dissemination, medical information
o Leveraged cooperation in cross-functional business teams, market access and market research teams.
o Budget planning and execution
* Beyond direct responsibilities:
o Led the company staff effectiveness from medical strategy standpoint
o Drove additional cross-functional and medical department projects.
o Personal coach and mentor for medical talents.

Bristol-Myers Squibb, Moscow (June, 2011 - June,2013).
Business Unit Director "Cardiovascular/Metabolics", since Oct., 2012 - June,2013.
o Responsible for business performance of BU and intercompany (with AZ) cooperation
o Strategy for medical, market access and marketing teams
o Management of cross-functional and cross alliances teams.
o Re-launch of diabetic product (Ongliza) in April, 2013.
o Pre-launch activities for early launch of core cardiovascular and diabetic products.
Business Unit Director "Oncology/Hematology", since June, 2011 till September, 2012.
o Responsible for the BU business performance
o Leadership within cross-functional team, innovative tools implementation
o Doubled the growth of sales in 2012 vs.2011 (11,8 mio USD), MS% achieved targeted level.
BAYER, Moscow.
April, 2009 till May, 2011.
Position: Head of Business Unit "General Medicine".
Managed the team of 150 employees. Business size 32 mio Euro, CAGR = 31% (best growth results among BUs in local Russian representation).
Remarks: responsible for BU business performance within matrix structure of the company with innovative and patented products, business development, marketing and launch excellence, ethical business running in line with legal and corporate compliance standards. Built synergies with other company departments.
Achievements. Change management successfully fulfilled with turn around strategy implementated. Top-line growth from 19,3 to 32,4 mio euro was achieved in Net Sales with bottom-line growth (profitability increased from 3,1% to 39,1%). Successful pre-launch based on medical evidence complemented with precise marketing launch of NOAC Xarelto (MS 1% within 4 months of sales).

PLIVA HRVATSKA d.o.o., A member of the Barr Group (USA). Moscow representation.

December, 2004 till April, 2009. The company was acquired by TEVA in 2008.
Position: Marketing Director.
Remarks: managing the team of 10 employees, with 6 direct reports. Leadership in marketing and sales teams. Business size: 135 mio USD.
- patented original, branded generics Rx and OTC portfolio management,
Achievements:
new structured medical and marketing short-term and long-term strategy for Russian market, which gave opportunity of business growth (net sales) from 30 mio USD to 135 mio USD (4,5-times) within 4 years.
Intensive program of new launches (11 totally) and re-launches resulted in achieving and maintaining leadership in neurology and analgesic market, antiinfectives, gastroenterology, cardiology, endocrinology, mens health ( Velafax MS 9,8%, Katadolon MS 1,4%, Sumamed MS 31,6%, Diuver MS 28,8%, Gastal MS 19%, Thioctacid MS 36,1%) where the products became of the 1[st] choice.
Fruitful cooperation and synergy was established with Sales Department locally and with HQ. Participant of successful change management in 2004-2005 in the company

BERLIN-CHEMIE / MENARINI Group, Moscow representation.
September, 1998 - June, 2004.
Position: Senior Product Manager (2 direct reports).
Cardiovascular franchise size 18 mio euro.
Remarks: full responsibility for the franchise management and marketing and medical performance. Best in the market scientific medical research and market preaparation.
Achievements. International Corporate Marketing Oscar Prize Winner for the best marketing and medical programs, resulted in 7-fold increase of cardio-vascular sales of the company since 1998 till 2004.

BOEHRINGER INGELHEIM Pharma GmbH, Moscow representation.
September 1996 - August 1998.
Position: Medical marketing Manager
Direct report to: Medical Director and Marketing Director.
Remarks: successful launch of original innovative 1[st] in class product (Movalis).
Responsible for medical and marketing activities in cardiovascular, gastroenterology, rheumatology, diabetes.


BUSINESS EDUCATION AND TRAININGS.
* Business training courses on selected topics, 2013-2015
* Leading Biopharma Leaders, BMS, Paris, 2012
* Leadership Excellence Program, Bayer, 2010.
* Training in "Tenders and Auctions" technologies, Moscow, 2010
* Marketing Excellence training, Bayer, 2009
* MBA Degree in Moscow Academy of Economy, 2006-2008
* Segmentation and Targeting Workshop, IMS, 2007
* Project Management Tools and Techniques, PMI, Dec., 2006
* Developing Leadership excellence, 3 grades, Zagreb, 2006
* Cooperation between marketing and sales, Moscow, IQ Center, 2005
* Effective corporate model of pharmaceutical sales, Moscow, IQ Center, 2004
* Advanced pharmaceutical marketing, MCE, Berlin, 2003
* Pharmaceutical Marketing Strategies, MCE, Brussels 2000
* Marketing Pharmaceutical Products, MCE, Brussels, 1999
* "To launch or not to launch", IMS, 1998
* "Territorial Analysis of Pharmaceutical Market", 1998 (Poland)
* SWOT-analysis, Center for Communication and Training, Vienna,1998
* Essentials of Pharmaceutical Marketing Planning and Conception, CHT, Baden,1998

Languages: English (fluent).
Personal Kolbe A profile (Kolbe A Index Results): "MANAGER".
Personal information: date and place of birth - 15.01.61, Russia, Moscow.
Personal features: conceptual-thinking, oriented on achieving team and corporate goals, proactive, looking beyond direct responsibilities.
Hobbies: paragliding, hill skiing, musical comedy.
Driving car license: yes.
Married: two sons and daughter